A facility for indoor admission of patients undergoing Radionuclide Therapy is available in ward D1. The department has been providing radionuclide therapy to patients with thyrotoxicosis and thyroid cancer with 131-I. There is a specifically designed isolation ward/beds for thyroid cancer patients duly approved by BARC/AERB. Other radionuclide therapies include bone pain palliation, Radiation synovectomy, PRRT, PSMA therapy, FAPi therapy, treatment of inoperable hepatocellular carcinoma (HCC) with 188Re-lipiodol etc.
Gamma Camera (SPECT/CT) Imaging
The department is equipped with 6 Gamma cameras including 3 dual head SPECT/CT systems. All types of nuclear medicine imaging procedures are performed in these imaging systems.
Non-Imaging Diagnostic Facilities
Thyroid uptake probe, gamma ray spectrometers, and Liquid Scintillation Counter are available for in-vivo and in-vitro studies such as RAIU, GFR.
PET and Cyclotron Facility
The department has one 11 MeV cyclotron for the production of positron emitters (such as 18F, 15O,13N, and 11C) and a well-equipped Radiochemistry laboratory for producing positron-emitting radiopharmaceuticals.
Two state-of-the-art PET/CT systems are available in the department. The most widely used PET radiopharmaceutical, 18F-FDG, is being routinely produced and utilized in the department. This modality has a tremendous role in oncology, cardiology, neurology, etc. with more than 80% application in oncology for staging, monitoring treatment response, differentiating benign and malignant lesions, and restaging. It also has a role in radiotherapy treatment planning. The department also has 68Ge-68Ga generators for preparing other positron-emitting radiopharmaceuticals.